Thomas Hallam

PALI

Thomas Hallam serves as Chief Executive Officer at Palisade Bio, Inc. (PALI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$36.7K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$36.7K

Companies Traded

PALI

Active Period

Sep 2021 – Aug 2022

3 total trades

Most Recent

Buy PALI

Aug 18, 2022 · $10.0K

Thomas Hallam's Insider Trading at Palisade Bio, Inc. (PALI)

Buys

3 · $36.7K

Sells

0 · $0.00

Total Shares Bought

56,000

Total Shares Sold

PALI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 18, 2022	Buy	40,000	$0.25	$10.0K	57,592
Mar 29, 2022	Buy	10,000	$1.18	$11.8K	17,592
Sep 22, 2021	Buy	6,000	$2.49	$14.9K	7,592

Related Insiders

Robert Baltera Jr.

director

PALIBuy · Jul 10, 2026

John David Finley

director, officer: CEO, CFO

PALISell · Jul 8, 2026

Mitchell Lawrence Jones

officer: Chief Medical Officer

PALISell · Jul 8, 2026

Donald Allen Williams

Director

PALIBuy · Jan 21, 2026

Explore More Insider Trading Data

PALI Insider Trading Activity

View all insider trades at Palisade Bio, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity